Abstract
Thyroid surgery is classified as a clean procedure and is associated with a low incidence of wound infections (0.3%). The majority of international guidelines do not recommend the use of systemic prophylactic antibiotic treatment in clean procedures. Antibiotic prophylaxis is not indicated in total thyroidectomy with or without neck dissection and should only be used in high-risk patients or when the operation is expected to last more than three hours (Ia,A). A single preoperative dose of prophylactic antibiotics must be administered 30 minutes prior to the induction of anaesthesia and should be re-administered only during the operation and if the latter exceeds three hours (Ia,A) Preoperative treatment with Lugol solution for 10 days blocks the release of thyroid hormone and significantly decreases the vascularity of the thyroid gland. Some endocrine surgeons administer Lugol solution 10 days preoperatively in order to decrease thyroid gland vascularity. However, the available studies are mostly based on empirical or indirect evaluations, such as the surgeon’s observations; consequently, objective results of the effects of Lugol solution on the thyroid gland are still difficult to achieve. The use of Lugol Solution in the preoperative preparation of patients with Grave’s Disease is acceptable (III,B). The development of DVT/PE complications in thyroidectomy has a low incidence when compared with the general surgical population. The operation is relatively short and allows immediate postoperative patient mobilization. Pharmacological prophylaxis against DVT is not necessary in thyroid surgery as the risk of postoperative bleeding is significantly greater than the risk of thromboembolism (Ib,A). Pharmacological prophylaxis against DVT is advised in high-risk patients (Ia,A). Mechanical prophylaxis against DVT is recommended in all patients as it demonstrates similar efficacy and risk reduction with pharmacological methods but without bleeding complications (Ia,A)
Similar content being viewed by others
References
Tourmousoglou CE, Yiannakopoulou EC, Kalapothaki V, Bramis J, Papadopoulos SJ. Adherence to guidelines for antibiotic prophylaxis in general surgery: a critical appraisal. J Antimicrob Chemother 2008;61:214–8.
Βώρος Δ. Χειρουργικές Λοιμώξεις 2002;16:258-62.
Schussler-Fiorenza CM, Burns CM, Chen H. The surgical management of Grave’s Disease. J Surg Res 2006;133:207–14.
Man LX, Beswick DM, Johnson JT. Antibiotic Prophylaxis in Uncontaminated Neck Dissection. Laryngoscope 2011;121:1473–7.
Moalem J, Ruan DT, Farkas RL,et al. Patterns of Antibiotic Prophylaxis Use for thyroidectomy and parathyroidectomy: Results of International Survey of Endocrine Surgeons. J Am Coll Surg 2010;210:949–56.
Erbil Y, Ozluk Y, Giris M, et al. Effect of Lugol Solution on thyroid gland blood flow and microvessel density in the patients with Grave’s Disease. J Clin Endocrinol Metab 2007;92:2182–9.
Jebreel A, England J, Bedford K, Murphy J, Karsai L, Atkin S. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases. Int J Exp Pathol 2007;88:271–7.
Avenia N, Sanguinetti A, Cirocchi R, et al. Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric Italian experience. Ann Surg Innov Res 2009;3:10.
Nagasaki T, Inaba M, Kumeda Y, Fujiwara-Ueda M, Hiura Y, Nishizama Y. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Grave’s disease. Biomed Phamacother 2007;61:472–6.
Hassan I, Danila R, Aljabri H, et al. Is rapid preparation for thyroidectomy in severe Grave’s disease beneficial? The relationship between clinical and immunohistochemical aspects. Endocrine 2008;33:189–95.
Shinall MC Jr, Broome JT, Baker A, Solorzano CC. Is potassium iodide solution necessary before total thyroidectomy for Grave’s disease? Ann Surg Oncol 2013;20:2964–7.
Autar R. Evidence of the prevention of venous thromboembolism. Br J Nurs 2006;15:980–6.
Joseph AC. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg 2010;199:S3–10.
Roy M, Rajamanickam V, Chen H, Sippel R. Is DVT prophylaxis necessary for thyroidectomy and parathyroidectomy? Surgery 2010;148:1163–9.
Lyman GH, Khorane AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 2013;31:2189–204.
Lopez JA, Chen J. Pathophysiology of venous thrombosis. Thromb Res 2009;123:30–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aggeli, C., Zografos, G., Anastasiou, E. et al. Special issues concerning thyroid surgery. Hellenic J Surg 87, 101–105 (2015). https://doi.org/10.1007/s13126-015-0192-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-015-0192-7